Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

28
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
28
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

12.2K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.2K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.5K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.5K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

4.3K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.3K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

130
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
130
Bacterial Translocation and Protein Secretion01:26

Bacterial Translocation and Protein Secretion

64
Bacterial protein secretion involves translocation systems to ensure proteins reach their designated locations, including the plasma membrane, periplasm, outer membrane, or the external environment. These translocation systems are vital for bacterial physiology, supporting processes like membrane assembly, enzymatic activity in the periplasm, and interactions with the external environment. The division of labor between Sec and Tat pathways ensures efficiency in handling proteins with diverse...
64

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Mucin-induced metabolic reprogramming in <i>Pseudomonas aeruginosa</i> clinical isolates.

mSystems·2026
Same author

Environmental former <i>Massilia</i> group bacteria secrete metabolites that promote <i>Leptospira</i> growth.

mSystems·2026
Same author

Hybrid genomes of three multidrug-resistant <i>Salmonella enterica</i> serovar Newport (REPJJP01) isolates from exotic captive felids in North Dakota, USA.

Microbiology resource announcements·2026
Same author

Chronic suppression of a multidrug-resistant Pseudomonas aeruginosa in prosthetic joint infection using personalized bacteriophage treatment.

Nature communications·2026
Same author

Hydrogen-Deuterium Back-Exchange for High-Resolution Mass-Spectrometry-Based Metabolite Characterization.

Analytical chemistry·2026
Same author

Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium.

Nature communications·2026
Same journal

Six ways to put the public at the heart of science and policy.

Nature·2026
Same journal

The complex truth about trust in science.

Nature·2026
Same journal

Have people stopped trusting science? The data tell a surprising story.

Nature·2026
Same journal

How FAIR data are helping to build trust in science.

Nature·2026
Same journal

Scientists should recognize their own political biases to build public trust.

Nature·2026
Same journal

Harmonizing standards and resources for the medical genome.

Nature·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Aug 21, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K

Los enterococos mejoran la patogénesis de Clostridioides difficile

Alexander B Smith1, Matthew L Jenior2, Orlaith Keenan1

  • 1Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Nature
|November 17, 2022
PubMed
Resumen
Este resumen es generado por máquina.

Las bacterias oportunistas del intestino, los enterococos, aumentan la virulencia de Clostridioides difficile al alterar el entorno metabólico del intestino. Esta interacción, que implica el intercambio de nutrientes y la reprogramación metabólica, aumenta la aptitud y la patogénesis de C. difficile.

Más Videos Relacionados

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.0K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K

Videos de Experimentos Relacionados

Last Updated: Aug 21, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.0K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K

Área de la Ciencia:

  • Microbiología
  • Investigación del microbioma intestinal
  • Enfermedades infecciosas

Sus antecedentes:

  • El tracto gastrointestinal alberga una comunidad polimicrobiana compleja que influye en la salud y la enfermedad del huésped.
  • Las interacciones microbianas son cruciales en las infecciones, sin embargo, los mecanismos por los cuales la microbiota comensal o patógena afecta la virulencia del patógeno no se comprenden completamente.
  • La infección por Clostridioides difficile (CDI) es un problema de salud importante, a menudo exacerbado por alteraciones en la microbiota intestinal.

Objetivo del estudio:

  • Investigar cómo la expansión de los enterococos, un grupo de patógenos oportunistas resistentes a los antibióticos, afecta la aptitud y la patogénesis de Clostridioides difficile.
  • Elucidar los mecanismos metabólicos subyacentes a la interacción entre los enterococos y C. difficile en el entorno intestinal.
  • Proporcionar conocimientos mecanicistas sobre el papel de la microbiota patógena en la gravedad de la ICD.

Principales métodos:

  • Se utilizaron modelos de infección en ratones para estudiar las interacciones microbianas in vivo.
  • Cambios metabólicos analizados en el entorno intestinal moldeado por enterococos.
  • Investigó la reprogramación del metabolismo de C. difficile en respuesta a nutrientes derivados de enterococos y señales metabólicas.
  • Muestras examinadas de pacientes con infección por C. difficile.

Principales resultados:

  • La expansión de los enterococos mejora la aptitud y la patogénesis de Clostridioides difficile en el intestino.
  • Los enterococos transforman el paisaje metabólico intestinal a través de la restricción de nutrientes y la alimentación cruzada, proporcionando aminoácidos fermentables (leucina, ornitina) que benefician a C. difficile.
  • El agotamiento enterocócico de la arginina actúa como una señal metabólica, aumentando la virulencia de C. difficile.
  • Se observaron interacciones microbianas entre enterococos y C. difficile en modelos de ratón y en pacientes con ICD humana.

Conclusiones:

  • Los enterococos promueven la patogénesis de C. difficile mediante la modulación del entorno metabólico intestinal.
  • Los intercambios metabólicos específicos, incluido el suministro y el agotamiento de nutrientes, median la mayor virulencia de C. difficile en presencia de enterococos.
  • Estos hallazgos ponen de relieve el papel significativo de la microbiota patógena en la conducción de la gravedad de las infecciones por C. difficile.